Reply: Re-evaluating Post-TAVR Antithrombotic Strategies in Nonanticoagulated Patients.
作者信息
Siami Sahand, Kazemian Sina, Maleki Saba, Ebrahimi Sara, Hosseini Kaveh
机构信息
Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
JACC Adv. 2025 Jul 7;4(8):101979. doi: 10.1016/j.jacadv.2025.101979.
Abstract
摘要
相似文献
1
Reply: Re-evaluating Post-TAVR Antithrombotic Strategies in Nonanticoagulated Patients.
JACC Adv. 2025 Jul 7;4(8):101979. doi: 10.1016/j.jacadv.2025.101979.
2
Re-Evaluating Post-TAVR Antithrombotic Strategies in Nonanticoagulated Patients.
JACC Adv. 2025 Jul 7;4(8):101983. doi: 10.1016/j.jacadv.2025.101983.
3
Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: A Network Meta-Analysis.
Curr Probl Cardiol. 2022 Dec;47(12):101348. doi: 10.1016/j.cpcardiol.2022.101348. Epub 2022 Aug 6.
4
Adjuvant Antithrombotic Therapy in TAVR.
Curr Cardiol Rep. 2017 May;19(5):41. doi: 10.1007/s11886-017-0850-1.
5
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: An Overview.
Struct Heart. 2022 Sep 15;6(5):100085. doi: 10.1016/j.shj.2022.100085. eCollection 2022 Oct.
6
Post-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients: Updated Systematic Review and Network Meta-Analysis.
JACC Adv. 2025 Mar 31;4(5):101719. doi: 10.1016/j.jacadv.2025.101719.
7
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials.
Clin Res Cardiol. 2022 Jan;111(1):14-22. doi: 10.1007/s00392-020-01791-x. Epub 2020 Dec 23.
8
Antithrombotic therapy after transcatheter aortic valve replacement: current perspective.
Curr Opin Cardiol. 2021 Mar 1;36(2):117-124. doi: 10.1097/HCO.0000000000000828.
9
Antithrombotic Therapy After TAVR.
Curr Vasc Pharmacol. 2018;16(5):437-445. doi: 10.2174/1570161116666180117145015.
10
Antithrombotic therapy following transcatheter aortic valve implantation: a Danish nationwide study.
Eur Heart J Qual Care Clin Outcomes. 2025 Aug 11;11(5):604-613. doi: 10.1093/ehjqcco/qcaf003.
本文引用的文献
1
Post-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients: Updated Systematic Review and Network Meta-Analysis.
JACC Adv. 2025 Mar 31;4(5):101719. doi: 10.1016/j.jacadv.2025.101719.
2
Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis.
Cochrane Database Syst Rev. 2025 Feb 24;2(2):CD013745. doi: 10.1002/14651858.CD013745.pub2.
3
Self-expanding and balloon-expandable valves in low risk TAVR patients.
Int J Cardiol. 2024 Jan 15;395:131431. doi: 10.1016/j.ijcard.2023.131431. Epub 2023 Oct 12.
4
Deep Learning in Prediction of Late Major Bleeding After Transcatheter Aortic Valve Replacement.
Clin Epidemiol. 2022 Jan 12;14:9-20. doi: 10.2147/CLEP.S333147. eCollection 2022.
5
Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1688-1703. doi: 10.1016/j.jcin.2021.06.020.
Zotero 插件